U
XTL Biopharmaceuticals Ltd. XTLB
$2.60 -$0.16-5.80%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 850.00K 911.00K 914.00K 1.02M 1.00M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 880.00K 941.00K 947.00K 1.05M 1.03M
Operating Income -880.00K -941.00K -947.00K -1.05M -1.03M
Income Before Tax -1.35M 1.50M 1.52M 656.00K 436.00K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -1.35 1.50 1.52 0.66 0.44
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -1.35M 1.50M 1.52M 656.00K 436.00K
EBIT -880.00K -941.00K -947.00K -1.05M -1.03M
EBITDA -879.20K -940.20K -946.20K -1.05M -1.03M
EPS Basic 0.00 0.00 0.00 0.00 0.00
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 2.18B 2.18B 2.17B 2.16B 2.14B
Average Diluted Shares Outstanding 2.18B 2.51B 2.51B 2.49B 2.47B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings